Research
BNP Paribas Downgrades Sanofi to Neutral Rating, Cuts PT
BNP Paribas on Monday downgraded French drugmaker Sanofi (SAN.PA, SANNV.PA) to neutral from outperform and decreased its price target to 85.00 euros from 100.00 euros.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
$SAN.PA$SANNV.PA
